Doris Ponce
Memorial Sloan Kettering Cancer Center · MSKCC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Doris Ponce as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:06 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07913672 · A Study of LBP-MARCO and Ruxolitinib in People With Graft-Versus-Host Disease (GVHD)Memorial Sloan Kettering Cancer Center · recruiting · Transplant Failure or Rejection of Bone Marrow (Graft vs Host Disease, GVHD) · principal investigator
- Ph2NCT07359859 · A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantMemorial Sloan Kettering Cancer Center · recruiting · Hematologic Malignancies · principal investigator
- Ph2NCT07006506 · A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell TransplantMemorial Sloan Kettering Cancer Center · recruiting · Graft Versus Host Disease, Graft Vs Host Disease, Hematologic Malignancy · principal investigator
- Ph1NCT04995653 · A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCTSeres Therapeutics, Inc. · completed · Allogeneic Hematopoietic Stem Cell Transplantation · principal investigator
- Ph1/Ph2NCT02406651 · Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHDEVIVE Biotechnology · completed · Acute Graft vs Host Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 17:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Intestinal microbiome restoration in allogeneic stem cell transplantationR01HL164902 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 2023 to 2026 · $442,500 awarded in 2026Same name and institution; not confirmed by an ID
- Microbiome manipulation through oral live biotherapeutic product (LBP) for the treatment of gut acute graft-versus-host disease (GVHD)R34HL184529 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 2026 · $281,722 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 17:06 UTC. The ranking covers the 200 most relevant of 34 PubMed records, and a shared surname and initials can bring in a namesake. All 34 on PubMed
- 694 citationsRCR 39.1
- Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.Sci Transl Med · 2018309 citationsRCR 11.1
- Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.J Clin Invest · 2020203 citationsRCR 9.8
- A randomized clinical trial of high volume peritoneal dialysis versus extended daily hemodialysis for acute kidney injury patients.Int Urol Nephrol · 201371 citationsRCR 2.7
- 47 citationsRCR 4.2
- High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.Biol Blood Marrow Transplant · 201541 citationsRCR 1.4
- Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.Biol Blood Marrow Transplant · 201741 citationsRCR 1.4
- Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection.Biol Blood Marrow Transplant · 201737 citationsRCR 1.5
- Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH).Nephrol Dial Transplant · 201535 citationsRCR 1.9
- Different prescribed doses of high-volume peritoneal dialysis and outcome of patients with acute kidney injury.Adv Perit Dial · 201133 citationsRCR 1.2